The caries preventive effect of 1-year use of low-dose xylitol chewing gum. A randomized placebo-controlled clinical trial in high-caries-risk adults by unknown
ORIGINAL ARTICLE
The caries preventive effect of 1-year use of low-dose xylitol
chewing gum. A randomized placebo-controlled clinical trial
in high-caries-risk adults
Fabio Cocco1,2 & Giovanna Carta1 & Maria Grazia Cagetti2,3 & Laura Strohmenger2,3 &
Peter Lingström4 & Guglielmo Campus1,2
Received: 25 August 2016 /Accepted: 7 February 2017
# The Author(s) 2017. This article is published with open access at Springerlink.com
Abstract
Objectives The caries preventive effect of long-term use
(1 year) of low-dosage (2.5 g/die) of xylitol chewing gum in
a high-caries-risk adult population was evaluated.
Materials and methods In this randomized clinical trial, 179
high-caries-risk adults were assigned to two experimental
groups, xylitol and polyols. Caries status, salivary mutans
streptococci (MS), and plaque pH were re-evaluated after
2 years from baseline in 66 xylitol and 64 polyol subjects.
Outcomes (the net caries increment for initial, moderate, and
extensive caries lesions and for the caries experience) were
evaluated using the nonparametric Mann–Whitney U test.
Results The total caries experience increment was 1.25 ± 1.26
in the xylitol group and 1.80 ± 2.33 in the polyol group
(p = 0.01). Subjects treated with xylitol chewing gums had a
reduction of risk rate at tooth level of 23% with respect to
those treated with polyols with a number needed to treat of
55 teeth. The area under the curve at pH 5.7 was statistically
significantly lower (p = 0.02) during the experimental period
in the xylitol group. A decrease of the concentration of sali-
vary MS was noted in the xylitol group (p < 0.01).
Conclusions Subjects using the low-dose xylitol chewing
gum showed a significantly lower increment of initial and
extensive caries lesions and overall a lower increment of car-
ies experience.
Clinical relevance One-year use of chewing gums provides
an effective means for the prevention of caries disease.
Trial registration number NCT02310308
Keywords Dental caries . Preventivemedicine . Xylitol .
Chewing gums . RCT
Introduction
Modern concepts regard caries as an interaction between host
andenvironmental factors,wherebiological, social, andbehav-
ioural factors are expressed in a highly complex interactive
manner with the dental biofilm as the key element [1]. Dietary
fermentable carbohydrates are the main triggering factor for
development of cariogenic biofilm [2]. When biofilm is ma-
tured, the presence of sugars promotes a higher plaque
cariogenicity, keeping frequently pH value under the critical
levels for the demineralization of enamel and dentine [3, 4].
The acidic environment within biofilm favours the growth of
more acid-tolerant bacteria such as mutans streptococci (MS)
and lactobacilli [5]. Preventive strategies are needed and rec-
ommended to control caries risk factors, mainly based on die-
tary changes, i.e. sweetener intake reduction, and enhancing
host resistance, i.e. twice-dailyuseoffluoride toothpastes [6,7].
However, the high-skewed caries prevalence distribution
suggests the need of developing new and effective preventive
approaches especially for high-risk groups [8, 9]. The use of
sugar-free chewing gums may contribute to prevent dental
caries [6, 10]. The increase of stimulated saliva flow rate pro-
motes oral clearance and enhances the buffering capacity to
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neutralize plaque pH [11]. It is described in literature that the
consumption of xylitol can lead to less plaque, less numbers of
MS, and a lower caries increment [6, 12, 13]. Although the
xylitol mechanisms are not fully known, several studies dem-
onstrate its benefits and clinical trials have shown that xylitol
possesses both noncariogenic and cariostatic properties [6, 10,
12, 14]. There is a debate on the effective dose; a total daily
dose from 3 to 8 g of xylitol is usually recommended for a
clinical effect. In children, the efficacy of low doses of xylitol
in caries prevention was speculated [15]; anyhow, the results
are inconclusive for long-term effectiveness regardingMS and
caries reduction [16].
The existing evidence of xylitol role in caries prevention
needs to be supplemented by well-designed randomized con-
trolled trials, especially in adults at high risk of caries.
Starting from this premise with the aim to assess the caries
preventive effect of long-term use of low dosage of xylitol
chewing gums in a high-caries-risk adult population, a ran-
domized placebo-controlled clinical trial with two arms was
designed and carried out.
Methods
This paper reports on findings obtained in a larger research
project that examines the effect of several functional foods
supplied through chewing gums on caries prevention in an
adult population. This paper was focused on the effect of
low-dose xylitol.
Ethical approval
The present study was carried out in Sassari (Italy) under the
supervision of the WHO Collaborating Centre for
Epidemiology and Community Dentistry of Milan, Italy, and
lasted from September 2012 to June 2015. The study was
designed as a randomized clinical trial, approved by the
Ethics Committee of the University of Sassari (n°1083/L 23/
07/2012), and registered (Protocol Registration Receipt
NCT02310308) at http://www.clinicaltrial.gov.
Study population
Data from the Italian National Institute for Statistics for 2011
gave the number of 30–45-year olds living in the town of
Sassari as 22,614.
The inclusion criteria were as follows: age range between
30 and 45 years; presence of a minimum of 12 natural teeth;
presence of at least one cavitated (D2/3) caries lesion, but not
more than three; a salivary concentration ofMS equal or upper
to 105 CFU/mL saliva; no current periodontitis (no sites of
probing pocket depth ≥5 mm or attachment loss of ≥2 mm,
apart from gingival recession); absence of dysfunction of
temporomandibular joint; good health systemically as
assessed by a medical questionnaire; no allergy to any of the
ingredients of the study products; no orthodontic banding or
removable prosthesis; and no use of antibiotics or participa-
tion in a clinical study in the previous 30 days. The use of
antibiotics was also recorded at interim examinations (6, 12,
and 24 months) before saliva sampling, and subjects using
antibiotics 30 days before the evaluation were excluded.
Sample size for preliminary screening was performed
through G*Power 3.1.3 for Apple using logistic regression
with an odds ratio of 1.8 and an error probability of 0.04;
the total sample was set at 312.
In order to get statistical comparable results, the number of
subjects per group to be included in the analysis was calculat-
ed. Considering a 40% difference among groups to be signif-
icant and a 95% probability of obtaining a significant differ-
ence between groups at the 5% severity, the resulting number
of subjects per group was set in 64.
With the collaboration of the municipal electoral registry of-
fice, a letter explaining the purpose of the study and the informed
consent were randomly distributed to 5% (1131 subjects) of the
age group considered living in Sassari. A total of 480 subjects
(42.4% acceptance rate) accepted to participate and were exam-
ined for conditions that would preclude participation. The flow
chart, displayed in Fig. 1, shows the design of the study.
Randomizationwasperformed(GCampus)usingExcel2014in
permuted blocks of two or four with random variation of the
blocking number, and two groupswere created: (1) the first group
receivedgumscontaining the samemixture of polyols except xyli-
tol;2) thesecondgroupreceivedgumscontaining thesamepolyols
mixtureplusalowamountofXylitol.Theclinicalexaminationwas
repeated at the end of the chewing gum administration period
(12months) andat the endof the experimental period (24months).
Abenchmarkexaminer (GCampus) trainedandcalibratedone
examiner (GCarta) that performed all dental screenings. Baseline
training consisted in 1-day (6 h) theoretical course, followed by
examination of 54 extracted teeth plus a session of 120 photo-
graphs of extracted teeth. Two days after the theoretical course, a
clinical training involving examination of 55 adults was per-
formed. The subjects were re-examined after 72 h. Inter-
examiner reliabilitywith the Bbenchmark^ (GCampus)was eval-
uated using fixed-effect analysis of variance. Intra-examiner re-
producibility was assessed as the percentage of agreement using
Cohen’s kappa statistic [17]. Good reliability was found between
examiner and benchmark (p = 0.15) with a low mean square of
error (0.47). Intra-examiner reliability was also high (Cohen’s
kappa=0.88). Interimandfollow-up trainingwasalsoperformed.
At the interim clinical evaluation (12 months), 47 adults not en-
rolled into the trial were re-examined after 72 h with a good reli-
ability between examiner and benchmark (p = 0.14) with amean
square of error (0.49) and a high intra-examiner reliability
(Cohen’s kappa = 0.91). Before the final follow-up examination
(24months),45adultsnot enrolled into the trialwere re-examined
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after 72 h with an inter-examiner reliability (examiner vs bench-
mark(p=0.14)withameansquareoferror (0.49)andahigh intra-
examiner reliability (Cohen’skappa=0.91). Subjectswere exam-
ined using a mouth mirror and a Community Periodontal Index
probe (approved by the WHO) under optimal lighting. The
ICDAS (International Caries Detection andAssessment System)
indexwasusedtoregistercariesat toothlevelas initialormoderate
or extensive lesions and the number of filled andmissing teeth for
caries [18]. Initial caries lesion can be defined as a primary lesion,
which has not reached the stage of an established lesion with
cavitation.Moderate caries lesions are defined as white or brown
spot lesion with localized enamel breakdown or an underlying
dentine shadow without visible dentine exposure. Severe caries
lesions are defined as distinct cavity in opaque or discoloured
enamelwith visible dentine [19]. Those participantswho referred
to consume more than three pieces of sugar-free chewing gum a
day were excluded. The elected participants agreed not to con-
sume any other chewing gums than those supplied for the study.
All participants were residents in an area with a low natural
fluoride content in the drinking water (0.04 mg/L) (http://
www.abbanoa.it/distretto-6-sassari1), but they reported to
use a fluoridated toothpaste on a regular basis.
Microbiological evaluation
Immediately after the clinical assessment, an evaluation ofMS
concentration in saliva was performed. Nonstimulated whole
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Discontinued intervention’s reasons: failed the examination or chewing gum delivery
Fig. 1 Flow chart of the study
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Kamstrup, Denmark). The samples were transported to the
Department of Microbiology and processed within 45 min
after collection. The samples were serially diluted in sterile
PBS (Sigma Chemicals, St. Louis, MO, USA). Aliquots of
5 μL were inoculated on mitis salivarius bacitracin agar, a
medium that at concentrations of bacteria 1 × 103 to
1 × 1010/mL shows a good sensitivity and selectivity in MS
detection. The plates were incubated in a 5% CO2 environ-
ment at 37 °C for 72 h after which the colony-forming units
were identified by morphology, size, and colour and counted
in a stereomicroscope.
Plaque pH measurements
Inter-proximal plaque pH of each subject was evaluated using
pH indicator strips [20], which measure a pH value in the
range 4.0–7.0 (Spezialindikator, pH range 4.0–7.0; Merck,
Darmstadt, Germany), with a resolution of 0.2–0.5 pH unit;
in addition, the strips are easy to use. The strips were cut into
four pieces (approx. 2 mm in width) in order to be more easily
inserted into the inter-proximal space and held into the inter-
dental space for 10 s, after which they were removed and their
colour compared to the colour index scheme supplied by the
manufacturer. The pH was determined to one decimal of the
value.
Plaque pHwas assessed at baseline, after 6 and 12months of
chewing gum use and 12 months after the cessation of chewing
gum use. For each subject, threemeasurements were carried out
on two sites, between the second premolar and the first molar,
right and left of the upper jaw; the average pH value was later
calculated. Recordings were performed before and at 2, 5, 10,
15, 20, and 30 min after a mouth rinse with 10% sucrose and
carried out by one examiner (FC). Area under the curve (AUC),
described as the area between reference pH (6.2 or 5.7) line and
the pH curve, was calculated using a computer-based program
[21]. The area under the curve at pH 5.7 and 6.2 (AUC5.7 and
AUC6.2) was used as a reference for the dissolution of enamel
and dentine, respectively.
Treatment and sample collection
Overall, 480 subjects were examined, 331 fulfilled the inclu-
sion criteria, and 179 accepted to be enrolled in the trial.
All chewing gums were produced and supplied by Perfetti
Van Melle SpA (Lainate, Italy). The polyol chewing gum was
sugar-free containing 28% isomalt, 31% sorbitol, 9% manni-
tol, and 1% maltitol syrup. Xylitol chewing-gum contained
30% of Xylitol, 26% Sorbitol, 11% Mannitol and 1%
Maltitol syrup.
All chewing gumsweighed 1.4 g each and were identical in
colour, shape, and taste. Chewing gums were supplied in plain
white containers coded as ‘green’ or ‘blue’ according to the
group. The code was sealed by an independent monitor and
not broken until the statistical analysis was finalized.
The subjects were instructed to chew for 5 min two pellets
in the morning, two after the midday meal, and one in the
afternoon; the total daily intake of xylitol was 2.5 g/day. The
subjects were asked to make no changes in their dietary and
oral hygiene habits. Tooth brushing was not allowed for at
least 1 h after the use of chewing gums. All subjects received
a fluoridated toothpaste containing 1450 ppm NaF
(Mentadent P; Unilever Italia, Milan, Italy) to be used during
the experimental period. They were also asked to avoid any
other oral hygiene adjuvant and any commercial xylitol or
sorbitol product throughout the study period. The body’s tol-
erance to different polyols was assessed by means of a ques-
tionnaire administered to the participants shortly after the gum
distribution had started and 6 months later, while the study
was still proceeding. The questions focused on the potential
side effects of using the gum. In order to evaluate the success
of the chewing gum intake, participants were given chewing
gums necessary for a single month at a time and asked to
return the empty packs when receiving those for the following
month.
Statistical analysis
The tooth as the unit of analysis was evaluated as follows:
first, the net caries increment for initial (ICDAS 1 and 2),
moderate (ICDAS 3 and 4), and extensive (ICDAS 5 and 6)
caries severity using ICDAS (Δ-initial, Δ-moderate, and Δ-
extensive) was calculated. The number of events is the sum of
theΔ-caries change of status recorded at baseline, 12 months
of gum use, and after 12 months of no-gum use. Secondly,
caries experience expressed as the sum of extensive caries
lesions plus the number of filled and extracted teeth due to
caries was calculated and consequently the caries increment
was recorded. Differences across mean number of events be-
tween groups for each variable were evaluated using the non-
parametric Mann–Whitney U test.
The data on inter-proximal plaque pH at baseline, 6 months
of gum use, 12 months of gum use, and after 12 months of no-
gum use were analysed for statistically significant differences
using repeated measures of ANOVA.
Differences in proportion relating to microbiological
counts at baseline and follow-ups were assessed using equal-
ity of proportion test. The lowness curve was used to describe
the trend of plaque pH and salivary MS. The effectiveness of
the treatment was assessed for those who fully followed the
protocol (per-protocol subjects) by calculating the reduction in
risk ratio (RRR) and the related number needed to treat (NNT)
value [22]. An event was defined as the change of status at
tooth level, i.e. the development of a new lesion or the pro-
gression of an existing lesion to a more severe stage. All data
were analysed using the software STATA® (v13 for Mac). For
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all statistical analyses, the statistical significance was set at
α = 0.05.
Results
A total of 130 subjects (72.62% of the initial sample) com-
pleted the trial (66 in the xylitol group and 64 in the polyol
group). In Fig. 1 is reported the flow chart of the study with the
number of the dropout subjects; the highest number of drop-
outs was reported at the 6-month evaluation. The main reason
for dropping out was the discontinued intervention. No side
effects were observed in any subjects. Moreover, the use of
chewing gums after the experimental period was fairly insig-
nificant; only 19 (10.61%) subjects reported the regular use
(once a day or more) of sugar-free chewing gum (data not in
table). The (Δ) caries values as the mean number of events at
the different time points of the trial (gum use 0–12months, no-
gum use 12–24months, and between baseline and 24months)
are reported in Table 1. The net caries increment for initial,
moderate, and extensive caries lesions using ICDAS (Δ-ini-
tial, Δ-moderate, and Δ-extensive) is displayed. No statisti-
cally significant differences between groups were recorded at
baseline, and no gender difference for each Δ-value was also
observed (data not in table). During the gum use, the Δ-
values were statistically significantly different between groups
for initial caries lesions (polyol 0.09 ± 0.15 and xylitol
0.05 ± 0.12, p = 0.01) and for extensive caries lesions (polyol
0.18 ± 0.38 and xylitol 0.11 ± 0.12, p = 0.02), while no sta-
tistical differences (p = 0.18) were recorded for moderate car-
ies lesions between groups. In the no-gum use period, no
statistically significant differences were recorded between
the two groups for each caries severity level. Regarding the
total duration of the trial (0–24 months), the Δ-values were
statistically significantly different for initial caries lesions
(polyol 0.20 ± 0.67 and xylitol 0.14 ± 0.37, p = 0.01) and
for extensive caries lesions (polyol 0.44 ± 0.73 and xylitol
0.30 ± 0.52, p = 0.03). No statistically significant difference
in the comparison between the two groups regarding moderate
caries lesions was observed (p = 0.12). The total caries expe-
rience increment was 1.80 ± 2.33 in the polyol group and
1.25 ± 1.26 in the xylitol group (p = 0.01).
Subjects treated with xylitol chewing gums had a reduction
of risk (RRR) rate at tooth level of 23% with respect to those
treated with polyols, with a NNT of 55 teeth. The event rate
was 0.087 in the polyol group and 0.066 in the xylitol group.
The chi-squared test was 3.18 (p = 0.07).
At baseline, plaque pH and salivaryMS concentration were
similar in the groups, with no statistically significant differ-
ences. Table 2 displays the mean ± standard deviation for
AUC5.7 and AUC6.2 during the trial. At baseline, the curves
of AUC5.7 and AUC6.2 were similar in the groups. The
AUC5.7 was statistically significantly different (p = 0.02)
during the experimental period in the xylitol group, ranging
from 11.5 ± 0.5 at baseline to 9.8 ± 0.3 at the 2-year evalua-
tion. The comparison between groups was statistically signif-
icantly different (p = 0.04) only at the end of the experimental
period. The AUC6.2 was statistically significantly different
(p < 0.01) in the xylitol group, ranging from 22.8 ± 0.6 at
baseline to 18.7 ± 0.6 at the 2-year evaluation. No statistically
significant differences were observed between groups. The
minimum pH showed small variations among the four time
points for the xylitol group, whereas in the polyol group, a
decrease was detected at 1- and 2-year evaluations.
Statistically significant differences were observed in the xyli-
tol group for both curves (β = 0.031, 95%CI = 0.003/0.081, and
p = 0.01 for the AUC5.7 and β = 1.167, 95%CI = −0.182/2.538,
and p = 0.09 for the AUC6.2).
Salivary bacteria (MS) results are shown in Table 3. At
baseline, all the subjects had a MS concentration ≥105 CFU/
mL; this was also one of the inclusion criteria for enrolment in
the trial. In both groups, the bacterial concentration decreases,
but only in the xylitol group the decrease was statistically
significant (p < 0.01); anyhow, comparison between groups
was statistically significant both at the end of gum use period
and at the end of the no-gum use period (p = 0.03 and p = 0.04,
respectively). A statistically significant trend in the MS reduc-
tion was observed in the xylitol group (β = 0.031,
95%CI = 0.003–0.081, and p = 0.01).
Discussion
The purpose of this study was to assess the caries preventive
effect of long-term use of low-dosage xylitol administered
through a chewing gum in a caries high-risk adult population.
To elucidate this aim, a two-arm randomized controlled inter-
vention trial was designed and carried out.
The use of sugar substitutes is an intervention able to reduce
caries risk [23, 24], and several nonfermentable sweeteners are
incorporated into many products, such as chewing gums, loz-
enges, candies, and syrup, with the xylitol as themain substitute
[15]. Several studies indicated an effect, dose- and frequency-
dependent, of xylitol with a total daily dose from 3 to 8 g a day
and a frequency of four to five times a day [16, 25].
In this trial, two types of chewing gumswere studied: a low
dosage (0.5 g/pellet) of xylitol chewing gum and a polyol
(isomalt, sorbitol, mannitol, and maltitol syrup) chewing
gum. The trial focused on caries increment (Δ-initial,Δ-mod-
erate, and Δ-extensive caries lesions and Δ-caries experi-
ence), plaque acidogenicity, and mutans streptococci concen-
tration in saliva. Two clinical caries evaluations were per-
formed, the first at the end of the chewing gum use period
(12 months from baseline) and the second at the end of the no-
gum use period (24 months from baseline), during which no
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other community-based caries prevention strategies were pur-
sued in the sample, except for the personal oral hygiene habits.
At the end of the gum use period, statistically significant
differences regarding initial and extensive Δ-caries values
were observed between the two groups. Subjects using the
low-dosage xylitol chewing gum showed significantly lower
caries increment. The comparison between the two follow-up
evaluations (12 and 24 months from baseline) showed no
statistically significant differences between the two groups,
but the comparison with respect to baseline was still statisti-
cally significant. Subjects using the low-dosage xylitol
chewing gum showed a significantly lower increment of initial
and extensive caries lesions and overall a lower increment of
caries experience. Few studies reported a long-term caries
preventive effect associated with xylitol gum that persists or
even increases over time [12, 26]. In this trial, the long-term
effect might be ascribed to the high statistically significant
values observed at the end of the chewing gum period
(12 months) and these statistically significant values persist
even at the 24-month evaluation.
Different results were reported in a recent multicenter
placebo-controlled randomized trial [27], where adults con-
sumed 5 g daily of xylitol or placebo lozenges during a 33-
month period. No significant effect was observed in the xylitol
group regarding reduction in caries increment even if a dose
almost double than those administered in the present study was
used. Several hypotheses might be speculated to assess these
different results.Although the twostudiesweresimilar regarding
thenumber of subjects, the sampleof thepresent studywashigh-
ly homogeneous (age range, caries risk factors, and number of
caries).Moreover, the total caries figurewas included in thepres-
ent study, considering even initial lesions andmissed teethdue to
caries, giving awider picture. In addition, timing andadministra-
tionmodalitieswere different in the two trials; in the present one,
Table 1 The (Δ) caries values as the mean number of events measured between baseline and 12-month follow-up examinations (Δ0–12), between 12-
month follow-up and 24-month follow-up (Δ12–24), and between baseline and 24-month follow-up (Δ0–24)
Polyol Xylitol (Mann Whitney U test )
Events (n) mean±SD Events (n) mean±SD p value
0 12 -initial 14 0.09±0.15 9 0.05±0.12 0.01
12-24 -initial 16 0.11±0.62 15 0.09±0.34 0.10
0-24 -initial 30 0.20±0.67 24 0.14±0.37 0.01
0-12 -moderate 16 0.10±0.35 13 0.07±0.23 0.18
12-24 -moderate 14 0.08±0.64 15 0.09±0.89 0.35
0-24 -moderate 31 0.18±0.72 28 0.16±0.82 0.12
0-12 -extensive 19 0.18±0.38 14 0.11±0.12 0.02
12-24 -extensive 32 0.26±0.38 19 0.19±0.88 0.17
0-24 -extensive 51 0.44±0.73 33 0.30±0.52 0.03
0-24 -caries 
experience
198 1.80±2.33 134 1.25±1.26 0.01
0-24 -filled teeth 120 1.12±2.89 82 0.73±1.41 0.03
0-24 -extracted teeth 27 0.24±0.51 19 0.22±0.36 0.82
Events Polyol Xylitol
New lesion 59 44
Initial to moderate 20 14
Moderate to extensive 28 24
Initial to extensive 5 3
Total Events 112 85
Non events 1290 1291














The difference was evaluated for caries severity (initial, moderate, and extensive) and caries experience (extensive caries plus the number of filled and
extracted teeth due to caries). The effectiveness of the treatment was assessed for those who fully followed the protocol (per-protocol subjects) by
calculating the reduction in risk ratio (RRR) and the related number needed to treat (NNT)-value. An event was defined as the change of status at tooth
level
χ2 = 3.18; p = 0.07; RRR = 0.23; 95%CI = −0.02/0.41; NNT = 55; 95%CI = −974/27
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xylitolwasadministeredviaachewinggum;this ledtotherelease
of xylitol times higher than that of other studies. Xylitol was
administered via a chewing gum far frommain meals, allowing
the polyol to act for a quite long period, and and due to a
prolonged residence time of xylitol in the oral cavity.
Plaque pH comparison between groups was statistically
significantly different, showing an area under the curve for
enamel dissolution less pronounced in the xylitol group at
the follow-up evaluations. Regarding the area under the curve
for dentine dissolution, no statistically significant difference
between groups was recorded, but a decrease in the area was
noted during the entire experimental period only in the xylitol
group. This pH figure reflects the trend of cariogenic bacteria
during the trial period. A statistically significant difference in
mutans streptococci concentration was evident between
groups both at the end of the chewing gum use period and at
the end of the no-gum use period. A growth-reducing effect of
xylitol on salivary MS has been described, suggesting a long-
term efficacy [24]. This finding seems to demonstrate a
prolonged effect of Xylitol on different plaque-related
variables, acidogenicity, and bacteria concentration, even if
the clinical efficacy seems to be limited at the gum use period.
Some limits of the study design need to be underlined. First
of all, the study population belonged to an age range, in which
the habit to chew daily chewing gum is not common, so it was
difficult to find a complete compliance and this might have
affected the dropout. The number of subjects and the inclusion
criteria do not allow to generalize the results to the general
population of this age group. It is disputable if the results of
this trial may not overlap to younger populations, taking into
consideration that the majority of studies were carried out on
children. A quite important issue is to determine if the preven-
tive effect is mainly due to xylitol amount or the frequency of
use. The results of the present study put some tiles to the
importance of the frequency of xylitol use; anyway, more
trials are needed to elucidate this aspect.
Although several studies were carried out on the caries pre-
ventive effect of Xylitol, this study holds almost unique charac-
teristics like the age of the subjects (adult population), the length
of the administration and the follow-up (12 and 24 months,
Table 2 Plaque pH: AUC5.7 and AUC6.2 (mean ± SD) during the experimental period
AUC5.7
Time Polyol Xylitol p value
one-way ANOVASubjects (n) Mean ± SD Subjects (n) Mean ± SD
Baseline 90 11.7 ± 0.6 89 11.5 ± 0.5 0.87
Gum use 6 months 79 11.4 ± 0.5 77 11.3 ± 0.3 0.90
12 months 72 9.9 ± 0.3 71 9.6 ± 0.4 0.78
No-gum use 24 months 64 11.4 ± 0.2 66 9.8 ± 0.3 0.04
p value one-way ANOVA 0.08 0.02
AUC6.2
Time Polyol Xylitol p value
one-way ANOVASubjects (n) Mean ± SD Subjects (n) Mean ± SD
Baseline 90 21.6 ± 0.2 89 22.8 ± 0.6 0.11
Gum use 6 months 79 18.9 ± 0.8 77 20.1 ± 0.5 0.07
12 months 72 19.0 ± 0.8 71 18.6 ± 0.7 0.26
No-gum use 24 months 64 19.5 ± 0.2 66 18.7 ± 0.6 0.15
p value one-way ANOVA 0.12 <0.01
Table 3 Concentration of salivaryMS (log10 CFU/mL in saliva: mean ± SE) at the different time points (baseline, 6 months of gum use, 12 months of
gum use, and after 12 months of no-gum use) in the two groups
Time Polyol Xylitol p value
one-way ANOVA
Subjects (n) Mean ± SD Subjects (n) Mean ± SD
Gum use Baseline 90 5.32 ± 0.43 89 5.41 ± 0.35 0.29
6 months 79 5.22 ± 0.21 77 5.33 ± 0.46 0.31
12 months 72 5.33 ± 0.42 71 5.16 ± 0.42 0.03
No-gum use 24 months 64 5.33 ± 0.46 66 5.15 ± 0.64 0.04
p value one-way ANOVA 0.42 <0.01
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respectively), the low dosage of xylitol administered (2.5 g/die),
and the administration vehicle (chewing gums).
In conclusion, a long use of xylitol chewing gums with low
concentration of polyol, controlling cariogenic bacteria con-
centration and plaque acidogenicity, provides an effective
means for the prevention of caries disease.
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